UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Activated CTLA‐4‐independent immunosuppression of Treg cells disturbs CTLA‐4 blockade‐mediated antitumor immunity

Cancer science, 2023-05, Vol.114 (5), p.1859-1870

2023

Volltextzugriff (PDF)

cyclic GMP‐AMP synthetase–STING signaling pathway is required for both the innate immune response against HBV and the suppression of HBV assembly

The FEBS journal, 2016-01, Vol.283 (1), p.144-156

2016

Volltextzugriff (PDF)

A new hepatoma cell line exhibiting high susceptibility to hepatitis B virus infection

Biochemical and biophysical research communications, 2019-07, Vol.515 (1), p.156-162

2019

Volltextzugriff (PDF)

Stem-like progenitor and terminally differentiated TFH-like CD4+ T cell exhaustion in the tumor microenvironment

Cell reports (Cambridge), 2024-02, Vol.43 (2), p.113797-113797, Article 113797

2024

Volltextzugriff (PDF)

Study of multiple genetic variations caused by persistent hepatitis C virus replication in long-term cell culture

Archives of virology, 2020-02, Vol.165 (2), p.331-343

2020

Volltextzugriff (PDF)

Anti-HCV activity of the Chinese medicinal fungus Cordyceps militaris

Biochemical and biophysical research communications, 2014-05, Vol.447 (2), p.341-345

2014

Volltextzugriff (PDF)

Antiviral mechanism of preclinical antimalarial compounds possessing multiple antiviral activities

FASEB bioAdvances, 2021-05, Vol.3 (5), p.356-373

2021

Volltextzugriff (PDF)

Establishment of hepatitis C virus RNA-replicating cell lines possessing ribavirin-resistant phenotype

PloS one, 2015-02, Vol.10 (2), p.e0118313-e0118313

2015

Volltextzugriff (PDF)

Genetic characterization of hepatitis C virus in long-term RNA replication using Li23 cell culture systems

PloS one, 2014-03, Vol.9 (3), p.e91156

2014

Volltextzugriff (PDF)

High‐level expression of STING restricts susceptibility to HBV by mediating type III IFN induction

FASEB bioAdvances, 2019-02, Vol.1 (2), p.67-80

2019

Volltextzugriff (PDF)

ULBP1 is induced by hepatitis C virus infection and is the target of the NK cell‐mediated innate immune response in human hepatocytes

FEBS open bio, 2018-03, Vol.8 (3), p.361-371

2018

Volltextzugriff (PDF)

Peroxisome proliferator-activated receptor delta antagonists inhibit hepatitis C virus RNA replication

Bioorganic & medicinal chemistry letters, 2013-09, Vol.23 (17), p.4774-4778

2013

Volltextzugriff (PDF)

Synthesis and inhibitory activity on hepatitis C virus RNA replication of 4-(1,1,1,3,3,3-hexafluoro-2-hydroxy-2-propyl)aniline analogs

Bioorganic & medicinal chemistry letters, 2014-09, Vol.24 (17), p.4276-4280

2014

Volltextzugriff (PDF)

Synthesis of 3′,4′-difluoro-3′-deoxyribonucleosides and its evaluation of the biological activities: Discovery of a novel type of anti-HCV agent 3′,4′-difluorocordycepin

Bioorganic & medicinal chemistry, 2014-11, Vol.22 (21), p.6174-6182

2014

Volltextzugriff (PDF)

New preclinical antimalarial drugs potently inhibit hepatitis C virus genotype 1b RNA replication

PloS one, 2013-08, Vol.8 (8), p.e72519

2013

Volltextzugriff (PDF)

Extracellular vesicles activate ATM‐Chk2 signaling pathway through the intercellular transfer of mitochondrial DNA in HBV‐infected human hepatocytes

The FASEB journal, 2021-06, Vol.35 (6), p.e21680-n/a

2021

Volltextzugriff (PDF)

Correction: New Preclinical Antimalarial Drugs Potently Inhibit Hepatitis C Virus Genotype 1b RNA Replication

PloS one, 2013-09, Vol.8 (9)

2013

Volltextzugriff (PDF)

Daunorubicin, a topoisomerase II poison, suppresses viral production of hepatitis B virus by inducing cGAS-dependent innate immune response

Biochemical and biophysical research communications, 2018-10, Vol.504 (4), p.672-678

2018

Volltextzugriff (PDF)

Multiple antiviral activities of the antimalarial and anti-hepatitis C drug candidates N-89 and N-251

Biochemistry and biophysics reports, 2018-09, Vol.15, p.1-6

2018

Volltextzugriff (PDF)

Identification of ribavirin-responsive cis-elements for GPAM suppression in the GPAM genome

Biochemical and biophysical research communications, 2020-11, Vol.533 (1), p.148-154

2020

Volltextzugriff (PDF)

Synthesis and In Vitro Activity of Pyrrolo[3,4-d]pyrimidine-2,5-diones as Potential Non-nucleoside HCV Inhibitors

Current enzyme inhibition, 2016-08, Vol.12 (2), p.170-176

2016

Volltextzugriff (PDF)

Combination therapy with hydrogen peroxide and irradiation promotes an abscopal effect in mouse models

Cancer science, 2023-10, Vol.114 (10), p.3848-3856

2023

Volltextzugriff (PDF)

Somatic mutations can induce a noninflamed tumour microenvironment via their original gene functions, despite deriving neoantigens

British journal of cancer, 2023-04, Vol.128 (6), p.1166-1175

2023

Volltextzugriff (PDF)

Daunorubicin, a topoisomerase II poison, suppresses viral production of hepatitis B virus by inducing cGAS-dependent innate immune response

Biochemical and biophysical research communications, 2018-10, Vol.504 (4), p.672-678

2018

Volltextzugriff (PDF)

Ribavirin-induced down-regulation of CCAAT/enhancer-binding protein α leads to suppression of lipogenesis

Biochemical journal, 2019-01, Vol.476 (1), p.137-149

2019

Volltextzugriff (PDF)

1 – 25 von 39

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(39)
Mit Volltextzugriff
(35)

Publikationsform

Artikel
(39)

Sprache

Englisch
(39)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Activated CTLA‐4‐independent immunosuppression of Treg cells disturbs CTLA‐4 blockade‐mediated antitumor immunity

cyclic GMP‐AMP synthetase–STING signaling pathway is required for both the innate immune response against HBV and the suppression of HBV assembly

A new hepatoma cell line exhibiting high susceptibility to hepatitis B virus infection

Stem-like progenitor and terminally differentiated TFH-like CD4+ T cell exhaustion in the tumor microenvironment

Study of multiple genetic variations caused by persistent hepatitis C virus replication in long-term cell culture

Anti-HCV activity of the Chinese medicinal fungus Cordyceps militaris

Antiviral mechanism of preclinical antimalarial compounds possessing multiple antiviral activities

Establishment of hepatitis C virus RNA-replicating cell lines possessing ribavirin-resistant phenotype

Genetic characterization of hepatitis C virus in long-term RNA replication using Li23 cell culture systems

High‐level expression of STING restricts susceptibility to HBV by mediating type III IFN induction

ULBP1 is induced by hepatitis C virus infection and is the target of the NK cell‐mediated innate immune response in human hepatocytes

Peroxisome proliferator-activated receptor delta antagonists inhibit hepatitis C virus RNA replication

Synthesis and inhibitory activity on hepatitis C virus RNA replication of 4-(1,1,1,3,3,3-hexafluoro-2-hydroxy-2-propyl)aniline analogs

Synthesis of 3′,4′-difluoro-3′-deoxyribonucleosides and its evaluation of the biological activities: Discovery of a novel type of anti-HCV agent 3′,4′-difluorocordycepin

New preclinical antimalarial drugs potently inhibit hepatitis C virus genotype 1b RNA replication

Extracellular vesicles activate ATM‐Chk2 signaling pathway through the intercellular transfer of mitochondrial DNA in HBV‐infected human hepatocytes

Correction: New Preclinical Antimalarial Drugs Potently Inhibit Hepatitis C Virus Genotype 1b RNA Replication

Daunorubicin, a topoisomerase II poison, suppresses viral production of hepatitis B virus by inducing cGAS-dependent innate immune response

Multiple antiviral activities of the antimalarial and anti-hepatitis C drug candidates N-89 and N-251

Identification of ribavirin-responsive cis-elements for GPAM suppression in the GPAM genome

Synthesis and In Vitro Activity of Pyrrolo[3,4-d]pyrimidine-2,5-diones as Potential Non-nucleoside HCV Inhibitors

Combination therapy with hydrogen peroxide and irradiation promotes an abscopal effect in mouse models

Somatic mutations can induce a noninflamed tumour microenvironment via their original gene functions, despite deriving neoantigens

Daunorubicin, a topoisomerase II poison, suppresses viral production of hepatitis B virus by inducing cGAS-dependent innate immune response

Ribavirin-induced down-regulation of CCAAT/enhancer-binding protein α leads to suppression of lipogenesis

Suchergebnisse filtern